DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional status on the other hand. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus to provide a suitable clinical response even before the symptoms arise.
Venture Capital
Current
Europe
Seed
Diagnostic
2020
Status
Creation Date
Investment Date
Fund Name